loading page

Management of Atrial Fibrillation in COVID-19 Pandemic
  • +6
  • Yu-Feng Hu,
  • Wen-Han Cheng,
  • Yuan Hung,
  • Wen-Yu Lin,
  • Tze-Fan Chao,
  • Jonan Liao,
  • Yenn-Jiang Lin,
  • Wei-Shiang Lin,
  • Shih-Ann Chen
Yu-Feng Hu
Taipei Veteran General Hospital
Author Profile
Wen-Han Cheng
Taipei Veterans General Hospital
Author Profile
Yuan Hung
Tri-Service General Hospital
Author Profile
Wen-Yu Lin
Tri-Service General Hospital, National Defense Medical Center
Author Profile
Tze-Fan Chao
Taipei Veterans General Hospital
Author Profile
Jonan Liao
Taipei Venterans General Hospital
Author Profile
Yenn-Jiang Lin
Taipei Veterans General Hospital
Author Profile
Wei-Shiang Lin
Tri-Service General Hospital, National Defense Medical Center
Author Profile
Shih-Ann Chen
Taipei Veterans General Hospital
Author Profile

Abstract

The health crisis due to coronavirus disease 2019 (COVID-19) shocks the world with more than million infections and casualties. COVID-19 could present from mild illness to multi-organ involvement, especially acute respiratory distress syndrome. Cardiac injury and arrhythmias including atrial fibrillation (AF) are not uncommon in COVID-19. COVID-19 is highly contagious, and the therapy against the virus remains premature and largely unknown. These make the management of AF patients during pandemic particularly challenging. We here describe possible pathophysiology link between COVID-19 and AF, and therapeutic considerations for AF patients during this pandemic.